PKI (6-22) amide (CAS 121932-06-7)
See product citations (11)
QUICK LINKS
PKI (6-22) Amide, also known as PKA Inhibitor, functions as a specific inhibitor of Protein Kinase A (PKA), a pivotal enzyme in the regulation of diverse cellular processes through phosphorylation of target proteins. By selectively binding to the catalytic subunit of PKA, PKI (6-22) Amide effectively disrupts the enzyme′s activity, providing useful for researchers to elucidate the roles of PKA-mediated signaling pathways in cellular functions. Its utility is especially prominent in the study of cellular communication, gene expression, and the molecular mechanisms underlying various biological processes. By inhibiting PKA, PKI (6-22) Amide allows for the exploration of the enzyme′s contributions to these processes, making it an essential compound in the toolkit of molecular and cellular biology research. Its specificity and efficacy in modulating PKA activity without affecting other kinases make it an ideal candidate for dissecting the complex signaling networks governed by protein phosphorylation.
PKI (6-22) amide (CAS 121932-06-7) References
- Systematic development of an enzymatic phosphorylation assay compatible with mass spectrometric detection. | de Boer, AR., et al. 2005. Anal Bioanal Chem. 381: 647-55. PMID: 15703914
- Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI). | Dalton, GD., et al. 2005. Neuropharmacology. 48: 648-57. PMID: 15814100
- ACTH inhibits bTREK-1 K+ channels through multiple cAMP-dependent signaling pathways. | Liu, H., et al. 2008. J Gen Physiol. 132: 279-94. PMID: 18663135
- N6-substituted cAMP analogs inhibit bTREK-1 K+ channels and stimulate cortisol secretion by a protein kinase A-independent mechanism. | Liu, H., et al. 2009. Mol Pharmacol. 76: 1290-301. PMID: 19734321
- Taurine supplementation: involvement of cholinergic/phospholipase C and protein kinase A pathways in potentiation of insulin secretion and Ca2+ handling in mouse pancreatic islets. | Ribeiro, RA., et al. 2010. Br J Nutr. 104: 1148-55. PMID: 20591207
- Synthesis, characterization and inhibitory activities of (4-N3[3,5-3H]Phe10)PKI(6-22)amide and its precursors: photoaffinity labeling peptides for the active site of cyclic AMP-dependent protein kinase. | Katz, BM., et al. 1989. Int J Pept Protein Res. 33: 439-45. PMID: 2550380
- Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. | Glass, DB., et al. 1989. J Biol Chem. 264: 14579-84. PMID: 2760075
- Glial interleukin-1β upregulates neuronal sodium channel 1.7 in trigeminal ganglion contributing to temporomandibular joint inflammatory hypernociception in rats. | Zhang, P., et al. 2018. J Neuroinflammation. 15: 117. PMID: 29678208
- The Kinase Specificity of Protein Kinase Inhibitor Peptide. | Chen, Y. and Sabatini, BL. 2021. Front Pharmacol. 12: 632815. PMID: 33584320
- Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase. | Glass, DB., et al. 1995. Protein Sci. 4: 405-15. PMID: 7795524
- Regulation of Chlamydomonas flagellar dynein by an axonemal protein kinase. | Howard, DR., et al. 1994. J Cell Biol. 127: 1683-92. PMID: 7798320
- Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. | Cassoni, P., et al. 1997. Int J Cancer. 72: 340-4. PMID: 9219843
- Modulation of the cardiac sodium current by inhalational anesthetics in the absence and presence of beta-stimulation. | Weigt, HU., et al. 1998. Anesthesiology. 88: 114-24. PMID: 9447864
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PKI (6-22) amide, 1 mg | sc-201160 | 1 mg | $160.00 |